Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools. Post navigation Emerging Phase III Results Show CALQUENCE Regimen Significantly Improved Progression-free Survival in Leukemia Patients PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy Demonstrates Higher Levels of Exon Skipping in Phase II Trial